Funds advised by private equity firm Permira, part of the SVG Capital group, have entered into agreements to acquire Tokyo-based Arysta Lifesciences, the world’s tenth largest agro-chemica
Funds advised by private equity firm Permira, part of the SVG Capital group, have entered into agreements to acquire Tokyo-based Arysta Lifesciences, the world’s tenth largest agro-chemicals company with a portfolio of more than 150 products marketed in some 125 countries.
Arysta Lifesciences, which was created by the 2001 merger of the agrochemicals divisions of Japanese trading houses Nichimen and Tomen, focuses on two main business lines, conventional crop protection (agriscience) and animal care products (life science). Since its establishment, the company has built a reputation as one of the most agile performers in the global agro-chemical industry.
The transaction is expected to close in the first quarter of next year, subject to regulatory approval. SVG Capital’s share of the investment is expected to be approximately GBP127.8m, subject to possible exchange rate fluctuations.
SVG Capital seeks to achieve capital appreciation by investing principally in private equity funds managed or advised by Permira. It also invests in private equity funds that invest in Japan, North America, Asia and the life sciences sectors, and in unquoted and quoted businesses through specialist funds and co-investments alongside these funds.
To complement this investment objective and create capital and income, SVG Capital’s fund management business structures, markets, manages and advises products for investment in private equity, private equity-related assets and other alternative asset classes, as well as in public equity using private equity techniques.
